1. Home
  2. MREO vs RDVT Comparison

MREO vs RDVT Comparison

Compare MREO & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • RDVT
  • Stock Information
  • Founded
  • MREO 2015
  • RDVT 2017
  • Country
  • MREO United Kingdom
  • RDVT United States
  • Employees
  • MREO N/A
  • RDVT N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • RDVT Computer Software: Prepackaged Software
  • Sector
  • MREO Health Care
  • RDVT Technology
  • Exchange
  • MREO Nasdaq
  • RDVT Nasdaq
  • Market Cap
  • MREO 281.6M
  • RDVT 606.7M
  • IPO Year
  • MREO N/A
  • RDVT N/A
  • Fundamental
  • Price
  • MREO $1.75
  • RDVT $50.66
  • Analyst Decision
  • MREO Strong Buy
  • RDVT
  • Analyst Count
  • MREO 5
  • RDVT 0
  • Target Price
  • MREO $7.40
  • RDVT N/A
  • AVG Volume (30 Days)
  • MREO 910.9K
  • RDVT 82.2K
  • Earning Date
  • MREO 11-11-2025
  • RDVT 11-05-2025
  • Dividend Yield
  • MREO N/A
  • RDVT 0.60%
  • EPS Growth
  • MREO N/A
  • RDVT N/A
  • EPS
  • MREO N/A
  • RDVT 0.61
  • Revenue
  • MREO $500,000.00
  • RDVT $82,399,000.00
  • Revenue This Year
  • MREO N/A
  • RDVT $19.34
  • Revenue Next Year
  • MREO $55.50
  • RDVT $13.60
  • P/E Ratio
  • MREO N/A
  • RDVT $81.53
  • Revenue Growth
  • MREO N/A
  • RDVT 22.14
  • 52 Week Low
  • MREO $1.47
  • RDVT $25.37
  • 52 Week High
  • MREO $4.72
  • RDVT $54.19
  • Technical
  • Relative Strength Index (RSI)
  • MREO 49.01
  • RDVT 62.39
  • Support Level
  • MREO $1.71
  • RDVT $47.13
  • Resistance Level
  • MREO $1.80
  • RDVT $51.47
  • Average True Range (ATR)
  • MREO 0.07
  • RDVT 1.75
  • MACD
  • MREO 0.01
  • RDVT -0.04
  • Stochastic Oscillator
  • MREO 45.45
  • RDVT 54.82

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About RDVT Red Violet Inc.

Red Violet Inc is a software and services company. It specializes in data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.

Share on Social Networks: